Cardio Diagnostics Holdings, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $14,825 | $34,890 | $17,065 | $950 | $901 |
| Operating income | -$6.5M | -$8.4M | -$7.2M | -$4.5M | -$620,448 |
| Operating expenses | $6.5M | $8.4M | $7.3M | $4.5M | $621,349 |
| Cash from operations | -$5.7M | -$5.0M | -$5.7M | -$5.1M | -$585,291 |
| Capital expenditure | $187,317 | $214,765 | $575,663 | — | — |
| Free cash flow | -$5.9M | -$5.2M | -$6.2M | — | — |
| Total assets | $7.8M | $10.6M | $4.5M | $6.2M | $1.1M |
| Total liabilities | $793,061 | $1.1M | $1.5M | $1.9M | $33,885 |
Shares outstanding 3.0M
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.